Dear Editor

Article

In answer to the question: "What specifically makes SLT different from ALT in its action?" we offer the following response:

Dear Dr Bastawrous,
In answer to the question: "What specifically makes SLT different from ALT in its action?" we offer the following response:

The mechanical theory of IOP reduction in argon laser trabeculoplasty (ALT) proposes that a thermal burn contracts tissue and stretches open those adjacent, untreated regions of the trabecular meshwork (TM) to increase outflow. However, in SLT, disruption or death of pigmented TM cells alone appears to induce a response that results in IOP reduction.

Previous clinical trials comparing ALT to SLT showed SLT to have equal or more favourable outcomes. However, SLT was better tolerated and produced less discomfort compared with ALT.

Suggested reading: M.A. Latina & J.M. deLeon. Selective Laser Trabeculoplasty. Ophthalmol. Clin. N. Am. 2005;409-419.

Arusha Gupta
SUNY Stony Brook School of Medicine, Stony Brook, New York, USA

Lawrence F. Jindra, MD
Columbia University, New York, USA

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.